Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate specific membrane antigen (PSMA) avid nonprostatic benign and malignant disease: a pictorial review.

Clinical radiology·2024
Same author

Assessing oral health and the minimally important differences in oral health-related quality of life of non-diabetic and diabetic patients: a cross-sectional study.

Australian dental journal·2024
Same author

Predictors of recurrence following laparoscopic minor hepatectomy for hepatocellular carcinoma in the UK.

Surgical oncology·2023
Same author

NIHR Imaging Group. Who are we and what do we do?

Clinical radiology·2023
Same author

Academic clinical fellows in radiology: how can we improve success?

Clinical radiology·2023
Same author

Current pressure on the UK imaging workforce deters imaging research in the NHS and requires urgent attention.

Clinical radiology·2022

Related Experiment Video

Updated: May 23, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
07:47

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

Functional imaging techniques in hepatocellular carcinoma.

V Goh1, D Sarker, S Osmany

  • 1Division of Imaging Sciences and Biomedical Engineering, Kings College London, London, UK.

European Journal of Nuclear Medicine and Molecular Imaging
|March 22, 2012
PubMed
Summary
This summary is machine-generated.

Novel therapies like sorafenib aid unresectable hepatocellular carcinoma survival. Functional imaging offers better treatment response assessment than traditional size-based methods for this cancer.

More Related Videos

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Related Experiment Videos

Last Updated: May 23, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
07:47

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Area of Science:

  • Oncology
  • Medical Imaging
  • Hepatology

Background:

  • Unresectable hepatocellular carcinoma (HCC) survival is improved by novel therapies, including tyrosine kinase inhibitors (TKIs) like sorafenib.
  • Conventional imaging (ultrasonography, CT, MRI) primarily uses tumor size change to assess TKI efficacy, often failing to recognize beneficial effects or identify non-responsive patients.
  • This limitation highlights the need for advanced imaging techniques to accurately evaluate treatment response in HCC.

Purpose of the Study:

  • To explore the potential of functional imaging methods for assessing therapeutic efficacy in hepatocellular carcinoma.
  • To address the limitations of conventional imaging in evaluating treatment response to novel biological therapies for HCC.
  • To identify imaging techniques that can more accurately detect beneficial tumor effects beyond size reduction.

Main Methods:

  • Review of current literature on functional imaging techniques applied to hepatocellular carcinoma.
  • Analysis of how functional imaging modalities assess tumor biology and treatment response.
  • Comparison of functional imaging with conventional size-based assessment methods (ultrasonography, CT, MRI).

Main Results:

  • Functional imaging methods show promise in detecting early therapeutic effects in HCC, independent of tumor shrinkage.
  • These techniques can potentially differentiate between active and inactive treatments, aiding clinical decision-making.
  • Improved assessment of treatment response may prevent unnecessary exposure to ineffective therapies and recognize beneficial outcomes earlier.

Conclusions:

  • Functional imaging represents a promising advancement for evaluating treatment response in unresectable hepatocellular carcinoma.
  • Adoption of functional imaging could lead to more personalized and effective management of HCC patients undergoing targeted therapy.
  • Further research and clinical validation are warranted to integrate functional imaging into standard HCC treatment assessment protocols.